ARTICLES BY THIS AUTHOR
- 3/2/2020
AAM aims to ensure access to generics, biosimilars during COVID-19 outbreak
In the wake of the coronavirus spreading, the Association for Accessible Medicines said it will work to help ensure that patients in the United States get access to generic and biosimilar medicines. - 3/2/2020
Briefs from pharmacy groups ask Supreme Court to uphold Arkansas PBM law
NACDS has filed a brief supporting an Arkansas law at question in an upcoming Supreme Court case, and several pharmacy groups including NCPA, APA, APhA and NASPA have filed a separate brief also in support of the law. - 3/2/2020
ANI gets FDA nod for memantine hydrochloride
Memantine hydrochloride ER capsules have a market value of approximately $127 million, according to IQVIA. - 2/28/2020
Bartell Drugs’ annual teddy bear drive expands participating organizations list
Bartell Drugs will match customers’ donations to provide teddy bears to help children in need. - 2/28/2020
Biohaven gets FDA nod for Nurtec ODT
Biohaven's Nurtec ODT is a single quick-dissolving oral tablet for adult patients with acute migraine. - 2/28/2020
Amplicare taps J. Bennet Waters as CEO; names Matthew Johnson president
Matthew Johnson, Amplicare's co-founder and CEO, will assume the new role of president; J. Bennet Waters will serve as CEO. - 2/28/2020
FDA approves Cerovene’s generic Daraprim
The FDA has approved the first generic of Daraprim (pyrimethamine) tablets when used with a group of medicines to treat bacterial infections. - 2/27/2020
Dr. Reddy’s launches generic Vimovo
Vimovo has a market value of approximately $414 million for the 12 months ended December 2019, according to IQVIA. - 2/27/2020
Mylan, Pfizer complete Viatris board of directors
Mylan and Pfizer’s soon to be combined company Viatris has selected the remaining members to its 13-member board of directors. - 2/27/2020
NACDS to serve as founding member of CDC’s National Hypertension Control Roundtable
By 2025, the National Hypertension Control Roundtable seeks to improve national hypertension control rates from 50% to 80%.